About Us

The word "Biopharmaceutical" is an amalgamation of Biotechnology and Pharmaceuticals. It reflects the convergence of what were once two distinct industries. Biopharmaceuticals are medicines typically derived from living systems and produced using Biotechnology- e.g. production of recombinant therapeutic proteins, vaccines, blood using microbial cells or somatic cells. The discipline also encompasses gene therapy. Genetically engineered biopharmaceuticals have impacted healthcare by providing medicines which are irreplaceable and are life-saving. The repertoire of these molecules is constantly expanding and success of established biopharmaceuticals is attracting biosimilar-production industry for providing these molecules at substantially lower cost to vast number of patients. However, these genetically engineered biopharmaceutical molecules are also extremely complex structures. Healthcare regulatory agencies demand detailed analysis of these molecules at all levels of development, commercial production and during stability and safety evaluations. Over the past decade, the BioPharma industry has developed many such Biologics, as they are also called. And follow-on versions of some of the earliest biologics made via recombinant DNA technology, including biosynthetic human insulin and human growth hormone, are now available. These are known as Biosimilars.